Journey Medical (DERM) Return on Invested Capital (2021 - 2025)

Journey Medical has reported Return on Invested Capital for 4 years, with the latest figure at 0.0% in Q4 2025.

• For the quarter ending Q4 2025, Return on Invested Capital changed N/A year-over-year to 0.0%; the trailing twelve-month figure through Dec 2025 stood at 0.0% (changed N/A YoY), and the FY2025 full-year result was 0.0%, changed 0.0% from the prior year.
• Return on Invested Capital for Q4 2025 stood at 0.0%, down from 0.0% in the prior quarter.
• The five-year high for Return on Invested Capital was 0.03% in Q3 2021, with the low at 0.02% in Q4 2021.
• Historically, Return on Invested Capital has averaged 0.0% across 4 years, with a median of 0.01% in 2022.
• The largest YoY upside for Return on Invested Capital was 2 bps in 2022 against a maximum downside of 3 bps in 2022.
• Journey Medical's Return on Invested Capital stood at 0.02% in 2021, then surged by 74 bps to 0.01% in 2022, then surged by 86 bps to 0.0% in 2023, then slumped by 210 bps to 0.0% in 2025.
• The last three Return on Invested Capital figures came in at 0.0% (Q4 2025), 0.0% (Q3 2025), and 0.0% (Q2 2025), per Business Quant data.